Evidence for a dopamine inhibitory post-synaptic potential in the brain of Helix aspersa.
D000200:Action Potentials / Q000187:drug effects*; D000818:Animals; D001921:Brain / Q000502:physiology*; D002712:Chlorides / Q000494:pharmacology; D004058:Diffusion; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000494:pharmacology / Q000502:physiology*; D004305:Dose-Response Relationship, Drug; D004558:Electric Stimulation; D004874:Ergonovine / Q000494:pharmacology; D005971:Glutamates / Q000494:pharmacology; D006892:Hydroxydopamines / Q000494:pharmacology; D066298:In Vitro Techniques; D008564:Membrane Potentials / Q000187:drug effects; D008750:Methyldopa / Q000494:pharmacology; D008781:Methyltyrosines / Q000494:pharmacology; D009433:Neural Inhibition / Q000187:drug effects; D009994:Osmolar Concentration; D010042:Ouabain / Q000494:pharmacology; D011188:Potassium / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D012908:Snails; D013569:Synapses / Q000187:drug effects / Q000502:physiology*
D002712:Chlorides; D005971:Glutamates; D006892:Hydroxydopamines; D008781:Methyltyrosines; D008750:Methyldopa; D010042:Ouabain; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D011188:Potassium; D004298:Dopamine; D004874:Ergonovine